V. Gutiérrez

A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status.

M. Benavides, M. Cobo, F. Carabantes, 2007, Lung cancer.

Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma

I. Barragán, E. Pérez-Ruiz, J. Oliver, 2021, Biomedicines.

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

M. Cobo, J. Trigo, V. Gutiérrez, 2017, Lung Cancer.

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study

B. Massuti, V. Calvo, M. Provencio, 2021, Translational lung cancer research.

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study.

R. Govindan, Keunchil Park, S. Peters, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

M. Provencio, I. Barneto, J. Valdivia, 2018, BMC Cancer.

Rovalpituzumab Tesirine as a Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From the Phase 3 MERU Study.

Melissa L. Johnson, C. H. van der Leest, B. Cho, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

R. Govindan, Keunchil Park, S. Peters, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

N. Viñolas, B. Massuti, M. Provencio, 2019, Lung cancer.

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

M. Provencio, I. Barneto, J. Valdivia, 2018, BMC Cancer.

[Afatinib in patients with squamous cell carcinoma of the lung: current context and the option of oral treatment].

M. Cobo, V. Gutiérrez, Omar López, 2016, Medicina clinica.